FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemical
The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.
FDA issues recall for antidepressant drug
The Federal Drug Administration issued a recall on Tuesday for a common medicine for depression. Over 7,000 bottles of Duloxetine were recalled due to the elevated presence of Nitrosamine, an ingredient believed to be cancerous,
FDA: Thousands of Bottles of Popular Antidepressant Recalled Over Potentially Cancer-Causing Chemical
Over 7,000 bottles of the antidepressant medication duloxetine, sold under the brand name Cymbalta, have been recalled, the FDA announced. The medication, produced by Towa Pharmaceutical Europe and distributed nationwide,
7,100 bottles of antidepressant recalled by FDA now in 2nd highest risk class
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
Thousands of bottles of popular antidepressant recalled: 3 things to know
Thousands of bottles of a popular antidepressant medication are being recalled due to the presence of what the National Library of Medicine describes as a toxic chemical, according to a notice from the U.S. Food and Drug Administration.
Thousands of duloxetine bottles, an antidepressant sold as Cymbalta, recalled over toxic chemical
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a toxic chemical.
Antidepressant recalled: 2nd-highest FDA risk level; drug contains cancerous chemical
The U.S. Food and Drug Administration updated the risk level of a recalled antidepressant due to the product containing high levels of a cancer-causing chemical.
FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why
The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the second-highest risk classification. Over 7,100 bottles of Duloxetine were recalled, including 500 delayed-release 20mg capsules. The lot number is 220128, and the expiration date is 12/2024, per the FDA report.
Thousands of bottles of common antidepressant Cymbalta recalled by FDA over cancer-causing chemical
Thousands of bottles of a commonly prescribed antidepressant drug have been recalled by the FDA because they were found to contain a suspected cancer-causing chemical. Over 7,100 bottles of Duloxetine,
Antidepressants recalled over cancer-causing chemical; should you stop taking your pills?
The FDA recalled thousands of bottles of antidepressants after finding high levels of potentially cancer-causing chemicals. Here's what to look for.
Antidepressant taken by millions urgently recalled after discovery of cancer-causing chemical
The FDA has ordered the removal of over 7,000 bottles of the drug duloxetine, known as Cymbalta, Drizalma Sprinkle, and Irenka, in the U.S. and advised that anyone taking those medications discuss it
This antidepressant is being recalled: Here’s why
The U.S. Food and Drug Administration (FDA) has issued a nationwide recall of thousands of bottles of antidepressants. These ...
Antidepressant recall: FDA upgrades medication risk class to 2nd highest level in recall update
The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...
Nationwide Antidepressant Recall Update As FDA Sets Risk Class
The recall of the Duloxetine Delayed-Release Capsules, produced by Towa Pharmaceutical Europe, was initiated on October 10 ...
WGAU Athens Radio on MSN8h
FDA issues Cymbalta recall
More than 7,100 bottles of Cymbalta is being pulled by the FDA after the toxic chemical was discovered. In addition to treat ...